These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 6144492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
    Tang W, Abbott FS.
    Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
    [Abstract] [Full Text] [Related]

  • 6. Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites.
    Zenser TV, Lakshmi VM, Davis BB.
    Drug Metab Dispos; 1999 Sep; 27(9):1064-7. PubMed ID: 10460807
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K, Farrell K, Abbott F.
    Drug Metab Dispos; 1991 Sep; 19(2):525-35. PubMed ID: 1676665
    [Abstract] [Full Text] [Related]

  • 9. Studies on the reactivity of acyl glucuronides--III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans.
    Williams AM, Worrall S, de Jersey J, Dickinson RG.
    Biochem Pharmacol; 1992 Feb 18; 43(4):745-55. PubMed ID: 1540228
    [Abstract] [Full Text] [Related]

  • 10. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.
    Wen Z, Stern ST, Martin DE, Lee KH, Smith PC.
    Drug Metab Dispos; 2006 Sep 18; 34(9):1436-42. PubMed ID: 16751262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K, Baillie TA.
    Drug Metab Dispos; 1993 Sep 18; 21(2):242-8. PubMed ID: 8097692
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW, Kauffman FC, Thurman RG.
    Cancer Res; 1984 Nov 18; 44(11):5073-8. PubMed ID: 6488167
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction.
    Dickinson RG, Kluck RM, Hooper WD, Patterson M, Chalk JB, Eadie MJ.
    Epilepsia; 1985 Nov 18; 26(6):589-93. PubMed ID: 3935422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.